Back to search

Article

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

2022-09-14

Abstract excerpt

<h4>Background</h4> Risk-assessment of endometrial cancer (EC) is based on clinicopathological factors and molecular subgroup. It is unclear whether adding hormone receptor expression, L1CAM expression or CTNNB1 status yields prognostic refinement. <h4>Methods</h4> Paraffin-embedded tumour samples of women with high-risk EC (HR-EC) from the PORTEC-3 trial (n=424), and a Dutch prospective clinical cohort called MST...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
239a8baa-ba43-5196-8d47-bf429cad0f32
DOI
10.1101/2022.09.13.22279853
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryDOI 10.1101/2022.09.13.22279853
Select a neighboring publication to make it the new centre.